Skip to main content
. 2022 Jan 19;27(3):624. doi: 10.3390/molecules27030624

Figure 5.

Figure 5

Model of ITCs’-mediated anti-inflammatory activity through inhibition of the JNK/AP-1/NF-κB pathway and activation of the Nrf2/HO-1 pathway, with concomitant upregulation of IL-10 and IL-4. Adapted from Subedi et al. [237].